Study of BPR-101 capsules with metronidazole for bacterial vaginosis
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50 who is sexually active and could become pregnant.
- You have been diagnosed with bacterial vaginosis (BV) confirmed by a doctor using specific tests (at least 3 of 4 Amsel criteria, including clue cells).
- You agree to use only the study treatments and no other vaginal products (like creams, gels, douches, tampons) during the trial.
- You have a regular menstrual cycle and are willing to use reliable birth control (or abstain from sex) during the study and for 3 months after.
- You do not have other vaginal infections (like yeast, trichomoniasis), pelvic infection, or certain other gynecologic conditions.
- You have not used antibiotics, antifungals, probiotics, or certain other medications within the past 2 weeks, and you can avoid them during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaginal gel for bacterial vaginosis (BV) in women aged 18-50. It aims to see if the gel is safe and works better than current treatments.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This trial compares different ways to treat bacterial vaginosis (a common vaginal infection) in women who are not pregnant and are between 18 and 45 years old. The goal is to find which treatment works best and is easiest to follow.
This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.
This study tests whether a probiotic product called Gyntima Balance can help prevent bacterial vaginosis (BV)—a common vaginal infection—from coming back repeatedly. If it works, it could reduce uncomfortable symptoms and the need for repeated antibiotic treatments.
Hear when a new Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.